Aditoprim
Chemical compound
From Wikipedia, the free encyclopedia
Aditoprim is an antibacterial dihydrofolate reductase inhibitor.[1] It is currently being investigated for veterinary use, mostly in China for the treatment of various Streptococcus caused conditions.[2][3] A 2025 study found that it is toxic to the human gut microbiota as most antibiotics are, and established a microbiologically acceptable daily intake of 91.67 µg/kg.BW/day.[4]
| Names | |
|---|---|
| Preferred IUPAC name
5-{[4-(Dimethylamino)-3,5-dimethoxyphenyl]methyl}pyrimidine-2,4-diamine | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C15H21N5O2 | |
| Molar mass | 303.366 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
